Ardent Health (NYSE:ARDT – Get Free Report)‘s stock had its “outperform” rating reissued by equities researchers at Leerink Partners in a research note issued to investors on Friday, Benzinga reports. They currently have a $14.00 target price on the stock. Leerink Partners’ price objective suggests a potential upside of 32.75% from the stock’s previous close. […]